FMP
XOMA Corporation
XOMA
NASDAQ
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
18.76 USD
-0.47 (-2.51%)
Free Cash Flow
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
29.39M
38.16M
6.03M
4.76M
28.49M
30.24M
32.1M
34.07M
36.17M
38.39M
Revenue %
-
29.86
-84.21
-21.06
498.72
6.15
6.15
6.15
6.15
Operating Cash Flow
10.09M
22.68M
-12.88M
-18.16M
-13.75M
-9.34M
-9.92M
-10.53M
-11.18M
-11.86M
Operating Cash Flow %
34.34
59.43
-213.69
-381.63
-48.26
-30.9
-30.9
-30.9
-30.9
Cap Ex
-1.21M
-26.5M
-23.25M
-17k
-20k
-10.52M
-11.17M
-11.86M
-12.59M
-13.36M
Cap Ex %
-4.11
-69.44
-385.71
-0.36
-0.07
-34.8
-34.8
-34.8
-34.8
Free Cash Flow
8.88M
-3.82M
-36.13M
-18.18M
-13.77M
-19.87M
-21.09M
-22.38M
-23.76M
-25.22M
